Cargando…
Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have spec...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595320/ https://www.ncbi.nlm.nih.gov/pubmed/26437964 http://dx.doi.org/10.1186/s12918-015-0214-7 |
_version_ | 1782393585364107264 |
---|---|
author | Zhang, Weiruo Kolte, Ritesh Dill, David L |
author_facet | Zhang, Weiruo Kolte, Ritesh Dill, David L |
author_sort | Zhang, Weiruo |
collection | PubMed |
description | BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have special properties that are not taken into account in existing methods for estimating kinetic parameters, including significant relative errors in measurements of metabolite concentrations and reaction rates, and reactions with multiple substrates and products, which are sometimes reversible. A new method is needed to estimate kinetic parameters taking into account these factors. RESULTS: A new method, InVEst (In Vivo Estimation), is described for estimating reaction kinetic parameters, which addresses the specific challenges of in vivo data. InVEst uses maximum likelihood estimation based on a model where all measurements have relative errors. Simulations show that InVEst produces accurate estimates for a reversible enzymatic reaction with multiple reactants and products, that estimated parameters can be used to predict the effects of genetic variants, and that InVEst is more accurate than general least squares and graphic methods on data with relative errors. InVEst uses the bootstrap method to evaluate the accuracy of its estimates. CONCLUSIONS: InVEst addresses several challenges of in vivo data, which are not taken into account by existing methods. When data have relative errors, InVEst produces more accurate and robust estimates. InVEst also provides useful information about estimation accuracy using bootstrapping. It has potential applications of quantifying the effects of genetic variants, inference of the target of a mutation or drug treatment and improving flux estimation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0214-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4595320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45953202015-10-08 Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach Zhang, Weiruo Kolte, Ritesh Dill, David L BMC Syst Biol Methodology Article BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have special properties that are not taken into account in existing methods for estimating kinetic parameters, including significant relative errors in measurements of metabolite concentrations and reaction rates, and reactions with multiple substrates and products, which are sometimes reversible. A new method is needed to estimate kinetic parameters taking into account these factors. RESULTS: A new method, InVEst (In Vivo Estimation), is described for estimating reaction kinetic parameters, which addresses the specific challenges of in vivo data. InVEst uses maximum likelihood estimation based on a model where all measurements have relative errors. Simulations show that InVEst produces accurate estimates for a reversible enzymatic reaction with multiple reactants and products, that estimated parameters can be used to predict the effects of genetic variants, and that InVEst is more accurate than general least squares and graphic methods on data with relative errors. InVEst uses the bootstrap method to evaluate the accuracy of its estimates. CONCLUSIONS: InVEst addresses several challenges of in vivo data, which are not taken into account by existing methods. When data have relative errors, InVEst produces more accurate and robust estimates. InVEst also provides useful information about estimation accuracy using bootstrapping. It has potential applications of quantifying the effects of genetic variants, inference of the target of a mutation or drug treatment and improving flux estimation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0214-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-05 /pmc/articles/PMC4595320/ /pubmed/26437964 http://dx.doi.org/10.1186/s12918-015-0214-7 Text en © Zhang et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Zhang, Weiruo Kolte, Ritesh Dill, David L Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title | Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title_full | Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title_fullStr | Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title_full_unstemmed | Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title_short | Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
title_sort | towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595320/ https://www.ncbi.nlm.nih.gov/pubmed/26437964 http://dx.doi.org/10.1186/s12918-015-0214-7 |
work_keys_str_mv | AT zhangweiruo towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach AT kolteritesh towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach AT dilldavidl towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach |